:

Yan Wang1,2, Shengjie Jin1,2, Qiqi Zhuang1,2

  • 1Department of Hematology The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou Zhejiang China.

MedComm
|December 4, 2023
PubMed
概括

化学抗原受体 (CAR) 自然杀手 (NK) 细胞为癌症免疫疗法提供了 CAR T 细胞的有希望的替代品,因为副作用较少,并且"现成"可用. 研究正在进行中,以克服诸如有限的扩散等挑战,以获得更广泛的临床应用.